SLC25A46 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.074200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.352600E-01
Normal-vs-Stage2
4.592000E-01
Normal-vs-Stage3
4.743500E-02
Normal-vs-Stage4
6.264800E-01
Stage1-vs-Stage2
2.441200E-01
Stage1-vs-Stage3
4.632300E-02
Stage1-vs-Stage4
5.709000E-01
Stage2-vs-Stage3
1.505590E-01
Stage2-vs-Stage4
6.423600E-02
Stage3-vs-Stage4
1.317830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.881400E-01
Normal-vs-AfricanAmerican
8.498200E-01
Normal-vs-Asian
3.356800E-01
Caucasian-vs-AfricanAmerican
6.007000E-01
Caucasian-vs-Asian
3.916600E-01
AfricanAmerican-vs-Asian
4.400200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.761600E-01
Normal-vs-Female
5.643800E-01
Male-vs-Female
6.401600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.794400E-01
Normal-vs-Age(41-60Yrs)
8.744000E-01
Normal-vs-Age(61-80Yrs)
3.619400E-01
Normal-vs-Age(81-100Yrs)
3.672200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.739600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.217400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.927000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.541840E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.873230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.658200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.618990E-01
Normal-vs-Daily Drinker
1.179040E-01
Normal-vs-Weekly Drinker
5.344600E-01
Normal-vs-Occasional Drinker
9.790000E-01
Normal-vs-Social Drinker
7.121200E-01
Non Drinker-vs-Daily Drinker
4.435400E-01
Non Drinker-vs-Weekly Drinker
6.137000E-01
Non Drinker-vs-Occasional Drinker
7.682400E-02
Non Drinker-vs-Social Drinker
1.481030E-01
Daily Drinker-vs-Weekly Drinker
3.064800E-01
Daily Drinker-vs-Occasional Drinker
3.330100E-02
Daily Drinker-vs-Social Drinker
7.231900E-02
Weekly Drinker-vs-Occasional Drinker
3.301600E-01
Weekly Drinker-vs-Social Drinker
5.993200E-01
Occasional Drinker-vs-Social Drinker
6.000600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.261400E-01
Normal-vs-Grade 2
1.419610E-01
Normal-vs-Grade 3
1.197980E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.785600E-01
Grade 1-vs-Grade 3
3.541200E-01
Grade 1-vs-Grade 4
3.261400E-01
Grade 2-vs-Grade 3
9.090600E-01
Grade 2-vs-Grade 4
1.419610E-01
Grade 3-vs-Grade 4
1.197980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.674200E-01
Normal-vs-NonDiabetic
4.023600E-01
Diabetic-vs-NonDiabetic
7.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.302840E-01
Normal-vs-NoPancreatitis
4.293200E-01
Pancreatitis-vs-NoPancreatitis
3.366200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.230800E-01
Normal-vs-N1
4.460400E-01
N0-vs-N1
6.526600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.385800E-01
Normal-vs-TP53-NonMutant
8.599800E-01
TP53-Mutant-vs-TP53-NonMutant
6.555600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
